| Company | Date | Round | Size | Participants |
| Galectin Therapeutics | 5/10 | Series B | $570k | 1 |
| Galectin Therapeutics | 5/10 | Series B | $310k | 1 |
| Galectin Therapeutics | 3/10 | Series B | $335k | 1 |
| Galectin Therapeutics | 2/10 | Series B | $325k | 1 |
| Galectin Therapeutics | 12/09 | Series B | $325k | 1 |
| Galectin Therapeutics | 11/09 | Series B | $325k | 1 |
| Galectin Therapeutics | 11/09 | Series B | $310k | 1 |
| Galectin Therapeutics | 10/09 | Series B | $325k | 1 |
| Galectin Therapeutics | 6/09 | Series B | $500k | 1 |
| Galectin Therapeutics | 5/09 | Series B | $900k | 1 |
| Galectin Therapeutics | 2/09 | Series B | $1.8M | 1 |